New Drug Development

New Drug Development (NDD) is a Japanese contract research organization (CRO) that provides comprehensive support for clinical trials and drug development. Founded in 1982, the company specializes in clinical monitoring, data management, and site management organization (SMO) services within the Japanese pharmaceutical market. NDD assists both domestic and international pharmaceutical companies in navigating the complex regulatory landscape of Japan's Pharmaceuticals and Medical Devices Agency (PMDA). Their service portfolio covers Phase I through Phase IV clinical trials, ensuring compliance with Good Clinical Practice (GCP) standards. The company plays a critical role in bridging the gap between drug discovery and commercialization for various therapeutic areas.